Prognostic Value of Cumulative Score Based on Preoperative Fibrinogen and Albumin Level in Skull Base Chordoma
Mingxuan Li,Jiwei Bai,Shuai Wang,Yixuan Zhai,Shuheng Zhang,Chuzhong Li,Jiang Du,Yazhuo Zhang
DOI: https://doi.org/10.2147/ott.s257779
IF: 4
2020-08-20
OncoTargets and Therapy
Abstract:Mingxuan Li, 1 Jiwei Bai, 2 Shuai Wang, 1 Yixuan Zhai, 3 Shuheng Zhang, 1 Chuzhong Li, 1 Jiang Du, 4 Yazhuo Zhang 1, 2, 5– 7 1 Beijing Neurosurgical Institute, Capital Medical University, Beijing, People's Republic of China; 2 Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, People's Republic of China; 3 Department of Neurosurgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China; 4 Department of Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, People's Republic of China; 5 Beijing Institute for Brain Disorders Brain Tumor Center, Beijing, People's Republic of China; 6 China National Clinical Research Center for Neurological Diseases, Beijing, People's Republic of China; 7 Key Laboratory of Central Nervous System Injury Research, Capital Medical University, Beijing, People's Republic of China Correspondence: Yazhuo Zhang Email zyz2004520@yeah.net Objective: Inflammation and malnutrition have been shown to be correlated with tumor progression and a poor prognosis in various cancers. However, the clinical implications of biomarkers of inflammation and malnutrition in chordoma have not been elucidated. We attempted to characterize the fibrinogen and albumin levels in skull base chordoma and investigate their correlations with clinicopathological data and survival. Methods: The preoperative levels of fibrinogen and albumin were assessed in 183 primary skull base chordoma patients. The cutoff values were determined by X-tile software, and their correlations with patient prognosis were further explored using the Kaplan–Meier curve and Cox proportional hazards regression analysis. In addition, the predictive performances of these markers in survival were evaluated by receiver operating characteristic curves. Results: The values of fibrinogen and albumin in skull base chordoma patients ranged from 1.73 to 7.40 and 37.6 to 53.0 g/L, respectively. The optimal cutoff values for fibrinogen and albumin were 3.29 and 44.60 g/L, respectively. Fibrinogen and albumin were correlated with the patient age and tumor pathology types. Albumin, but not fibrinogen, was associated with the patients' progression-free survival and overall survival. Importantly, the FA score, which combines fibrinogen and albumin, could independently predict both progression-free survival and overall survival, and enhanced the performance of fibrinogen or albumin in survival prediction in skull base chordoma. Conclusion: Our data reveal the clinical prognostic role of albumin and suggest that the FA score may be a valuable prognostic grading system in skull base chordoma. Keywords: skull base chordoma, fibrinogen, albumin, biomarker, prognosis
oncology,biotechnology & applied microbiology